Factors affecting outcomes after endovascular treatment for large-vessel stroke
Official title: Factors Affecting Clinical and Radiological Outcome in Endovascular Management of Acute Ischemic Stroke Due to Large Vessel Occlusion
Run by Sohag University · NCT07740018 · Data updated 2026-11-12
This study tests how different factors influence recovery after mechanical clot removal in adults with acute ischemic stroke due to large vessel blockage.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | August 1, 2028 |
| Study ends | August 1, 2028 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT07740018 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with acute ischemic stroke due to large-vessel occlusion eligible for endovascular thrombectomy.
✕Probably not a fit
Patients outside the specified age range or without eligible large-vessel occlusion, and those with imaging profiles not meeting core/penumbra criteria, may see limited or no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines endovascular thrombectomy for acute ischemic stroke caused by large vessel occlusion. It includes adults aged 18 to 80 presenting within 24 hours, with imaging criteria to identify salvageable brain tissue in later windows. Outcomes are evaluated in relation to clinical and radiological factors to understand what influences recovery. Time-sensitive treatment and rapid diagnosis are emphasized, with emphasis on broad imaging selection criteria to minimize delays. The trial is conducted under Sohag University as the lead sponsor, at Sohag University Faculty of Medicine in Sohag, Egypt.
Why it matters
Potential benefit: If successful, the study could clarify which patient characteristics predict better outcomes after thrombectomy, helping clinicians select and optimize therapy.
How similar studies have gone: Existing research supports benefit of thrombectomy in selected AIS patients, but this study aims to refine understanding of factors affecting outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * General Criteria (Applicable to All Time Windows) * Age ≥ 18 to 80 years old. * Acute ischemic stroke due to large vessel occlusion (LVO) presenting within 24 hours from symptom onset or last known well. Occlusion involving one of the following vessels: * internal carotid artery (ICA) * M1 segment of the middle cerebral artery (MCA) * A1 segment of the anterior cerebral artery (ACA) * P1 segment of the posterior cerebral artery (PCA) * Basilar artery (BA) * V4 segment of the vertebral artery (VA) * National Institutes of Health Stroke Scale (NIHSS) score ≥ 6. Patients Presenting Within 0-6 Hours from Symptom Onset or Last Known Well , * Alberta Stroke Program Early CT Score (ASPECTS) ≥ 6. Patients presenting 6-24 hours from the last known well, imaging eligibility based on : * Estimated ischemic core volume \< 70 mL. * Ratio of critically hypoperfused tissue to ischemic core (mismatch ratio) ≥ 1.8. * Absolute volume of potentially salvageable tissue (Diffusion to flair mismatch volume) ≥ 15 mL. Exclusion Criteria: * • Patients with stroke resulting from etiologies other than LVO. * Individuals with a history of previous strokes. * Hemorrhagic stroke * Large established infarction (e.g., ASPECTS \< 6 for patients within the early time window or imaging findings not meeting eligibility criteria in the late window). * Patients presenting 6-24 hours from the last known well who do not meet advanced imaging selection criteria (e.g., DEFUSE 3 or DAWN eligibility criteria). * Pre-stroke disability with a modified Rankin Scale (mRS) score ≥2. * Rapid improvement in neurological status to an NIHSS \< 6 or evidence of vessel recanalization prior to randomization.
Where it's running
-
Sohag University Faculty of Medicine
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Mohammed ahmed kassem, assistant lecturer
- Email: mohamed011152@med.sohag.edu.eg
- Phone: 00201098003153
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobilisation After Endovascular Stroke Treatment
This study checks whether moving around 12 hours after endovascular stroke treatment is as safe as moving around 24 hours for people with an acute ischemic stroke.
-
Intra-arterial Thrombolysis After Endovascular Thrombectomy in AIS
This trial tests whether giving intra-arterial thrombolysis with tenecteplase or alteplase after endovascular thrombectomy helps improve recovery in adults with acute ischemic stroke.
-
Minocycline after successful recanalization in acute anterior circulation stroke
This trial tests whether adding minocycline after a successful endovascular thrombectomy helps people recover better after an acute anterior circulation stroke.
-
Minocycline after successful reopening of posterior circulation stroke with endovascular therapy
This trial tests whether adding minocycline after successful thrombectomy helps people recover better from a posterior circulation stroke.
-
Transcranial magnetic stimulation after thrombectomy for acute ischemic stroke
This trial will try short sessions of continuous theta-burst transcranial magnetic stimulation (cTBS) to help recovery in adults who had an acute anterior-circulation ischemic stroke and successful endovascular thrombectomy.
-
Evaluating a new catheter for treating severe strokes
This study tests if a new type of catheter can help people with severe strokes recover better than the usual treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.